Advisors Preferred’s Medifast MED Stock Holding History

Advisors Preferred’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-282	Closed	-$29K	–	287
2019 Q3	$29K	Sell	282 -114	-29%	-$12.3K	0.01%	168
2019 Q2	$49K	Buy	+396	New	+$55K	0.02%	136
2018 Q4	–	Sell	-1,436	Closed	-$318K	–	178
2018 Q3	$318K	Buy	+1,436	New	+$291K	0.14%	60

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Advisors Preferred's MED Position: Q4 2019 in Review

Advisors Preferred sold out of Medifast (MED) in Q4 2019, closing a stake of 282 shares — an estimated $29K sold.

Advisors Preferred first reported a position in MED in Q3 2018 and held it in 3 quarters. The position peaked at $318K in Q3 2018. 219 funds tracked by Wall St. Rank hold MED as of Q4 2019.

Advisors Preferred reported no remaining Medifast position as of Q4 2019 after selling out during the quarter.
Advisors Preferred sold 282 Medifast shares in Q4 2019, an estimated $29K.
Advisors Preferred first reported a position in Medifast in Q3 2018 and held it in 3 quarters.
Advisors Preferred's Medifast position peaked at $318K in Q3 2018.
219 funds tracked by Wall St. Rank held Medifast as of Q4 2019.

Based on Advisors Preferred's 13F filing for Q4 2019, filed 21 Jan 2020.